Literature DB >> 3572020

Community-acquired pneumonia in an adult due to a multiply-resistant pneumococcus.

H Sacho, K P Klugman, H J Koornhof, P Ruff.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3572020     DOI: 10.1016/s0163-4453(87)92127-x

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


× No keyword cloud information.
  7 in total

Review 1.  Role of beta-lactam agents in the treatment of community-acquired pneumonia.

Authors:  J Garau
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-02       Impact factor: 3.267

Review 2.  Drug-resistant pneumococcal pneumonia: clinical relevance and approach to management.

Authors:  J D Fuller; A McGeer; D E Low
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-12       Impact factor: 3.267

3.  Pneumonia Due to Drug-Resistant Streptococcus pneumoniae.

Authors:  Sadao Jinno; Michael R Jacobs
Journal:  Curr Infect Dis Rep       Date:  2012-06       Impact factor: 3.725

Review 4.  Vaccination against pneumococcal infection.

Authors:  N D Noah
Journal:  BMJ       Date:  1988-11-26

5.  Activity of teicoplanin and vancomycin against penicillin-resistant pneumococci.

Authors:  K P Klugman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-01       Impact factor: 3.267

Review 6.  Penicillin- and cephalosporin-resistant Streptococcus pneumoniae. Emerging treatment for an emerging problem.

Authors:  K P Klugman; C Feldman
Journal:  Drugs       Date:  1999-07       Impact factor: 9.546

Review 7.  Pneumococcal resistance to antibiotics.

Authors:  K P Klugman
Journal:  Clin Microbiol Rev       Date:  1990-04       Impact factor: 26.132

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.